Investigation of the Effect of Different Eye Exercises on Hypermetropia in School-age Children
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03347734|
Recruitment Status : Completed
First Posted : November 20, 2017
Last Update Posted : May 11, 2018
|Condition or disease||Intervention/treatment||Phase|
|Hyperopia||Behavioral: Eye exercises group Behavioral: Convergence exercise group Behavioral: Oculomotor Exercise Group (OMEG)||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||60 participants|
|Intervention Model:||Parallel Assignment|
|Intervention Model Description:||Randomized Controlled Double-Blind Study|
|Masking:||Double (Participant, Outcomes Assessor)|
|Masking Description:||Participants do not have information about treatment content and groups. He is only aware of exercise therapy applied to him.The ophthalmologist performed evaluations without knowledge of the groups in which the participants were included and of exercise therapy administered.|
|Official Title:||Randomized Controlled, Double-Blind Trial of Investigation of the Effect of Different Eye Exercises on Hypermetropia in School-age Children|
|Actual Study Start Date :||February 1, 2017|
|Actual Primary Completion Date :||June 14, 2017|
|Actual Study Completion Date :||October 25, 2017|
Experimental: Eye Exercises Group (EEG)
For the individuals in the group of eye exercises (GEG), 10 repetitive eye exercises protocol was organized as a home program for 6 weeks, twice a day in the morning and evening each day of the week.
Behavioral: Eye exercises group
Experimental: Convergence Exercise Group (CEG)
For the individuals in the group of convergence exercise, 5 minutes convergence exercise protocol was organized as a home program for 6 weeks, twice a day in the morning and evening each day of the week.
Behavioral: Convergence exercise group
Experimental: Oculomotor Exercise Group (OMEG)
For the individuals in the group of oculomotor exercise, 10 repetitive, four different oculomotor exercise protocols with eye stabilization were organized as home programs for 6 weeks, twice a day in the morning and evening each day of the week.
Behavioral: Oculomotor Exercise Group (OMEG)
- Visual acuity [ Time Frame: 6 week ]Snellen chart was used for visual acuity measurement. Snellen "E" was asked to be registered or registered to the device. In visual acuity measurement, individuals were evaluated with their own glasses.
- Hypermetropic grade [ Time Frame: 6 week ]The refraction defects were measured by autorefractometry, which is frequently used because it provides fast and reliable results in clinic. In the autorefractometry method, the infrared rays sent to the patient's eye are reflected from the retina back to the device and evaluate the refraction defect of the patient
- Near and sharp visual acuity [ Time Frame: 6 week ]Subscales of activities of daily vision scale, individuals questioning the near vision and sharp vision scores were used. Individuals question the extent to which they can not perform activities because of the difficulty of seeing them, and the degree of difficulty they experience while doing the activity. Points in different categories are summed and converted to a value between 0-100 by the formula. High score gives good visual acuity.
- Health-related quality of life [ Time Frame: 6 week ]Participants' health-related quality of life was assessed using the Pediatric Quality of Life Inventory Version 4.0 (PedSQI 4.0) Children Report. Score is calculated in 3 areas as total score of scale (SST), total physical health score (FSTP) and total score of psychosocial health (PSTP) which is calculated by calculating emotional, social and school functioning.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03347734
|Istanbul Medipol Universty|
|Istanbul, Beykoz, Turkey|
|Study Director:||Candan Algun||Faculty of Health Sciences|